|
시장보고서
상품코드
1625479
자가면역질환 진단 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제품 유형별, 검사 유형별, 최종 사용자별, 지역별 - 시장 예측(2025-2034년)Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 세계 자가면역질환 진단 시장 규모는 2034년까지 71억 4,632만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
자가면역질환 진단 시장은 헬스케어 및 진단 산업의 한 분야입니다. 이 시장은 첨단 진단 도구와 기술을 통해 자가면역질환을 식별하고 관리하는 데 초점을 맞추었습니다. 자가면역질환은 면역체계가 신체 조직을 공격하여 만성적이고 잠재적으로 다양한 증상을 유발하는 질환입니다. 이 시장은 혈액 검사, 영상 진단 기술, 분자 분석 등 이러한 상태를 감지하는 데 사용되는 진단 검사 및 기술을 포괄합니다.
전 세계적으로 자가면역질환의 유병률이 증가함에 따라 조기에 정확한 진단 도구에 대한 수요가 증가하고 있습니다. 이러한 질환에 대한 인식이 높아짐에 따라 환자와 의료진은 보다 정확하고 효율적인 진단 솔루션을 요구하고 있습니다. 또한, 개인 맞춤형 의료 및 첨단 치료 접근법의 채택이 증가함에 따라 정확한 진단이 필요해지면서 시장 성장에 더욱 박차를 가하고 있습니다. 자가면역 질환 및 진단 연구에 대한 정부 이니셔티브와 자금 지원은 새로운 진단 방법의 개발에 기여하고 있으며, 이로 인해 시장 기회가 증가하고 있습니다.
2021년 AMP(Accelerating Medicines Partnership) 프로그램은 AMP AIM(Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases) 프로그램을 도입했습니다. AMP AIM(AMP Autoimmune and Immune-Mediated Diseases) 이니셔티브는 자가면역질환에 대한 인식을 높이고 조기 검진을 촉진함으로써 시장을 주도하고 있습니다.
자가면역질환 진단 시장은 더 높은 정확도와 빠른 결과를 제공하는 고도의 자동화된 진단 솔루션으로 빠르게 전환하고 있습니다. 인공지능(AI)과 머신러닝(ML)을 진단 플랫폼에 통합함으로써 자가면역질환을 감지하고 모니터링하는 방법을 변화시켜 효율성과 정확성을 향상시키고 있습니다. 또한, 기존 방법보다 환자 친화적인 비침습적 진단 기술 개발에 점점 더 많은 관심이 집중되고 있습니다.
지난 7월, KSL Beutner Laboratories(Beutner)는 미국에서 간접 면역 형광(IIF) 혈청 혈액 검사를 시작했다고 발표했습니다. 이 검사는 지속성 자가면역질환인 점막 천포창(MMP)과 관련된 항원인 라미닌332를 효과적으로 검출합니다. 이러한 진단법의 발전은 자가면역질환 진단 시장의 성장을 주도하고 있습니다.
자가면역질환 진단 시장 보고서 하이라이트
유형별로는 전신성 자가면역질환 진단 부문이 자가면역질환 진단 시장의 매출 점유율을 주도하고 있으며, 이는 주로 의료진과 환자들의 인식 개선에 기인합니다.
검사 유형별로는 자가면역질환의 유병률 증가와 진단 기술의 발전으로 항핵항체(ANA) 검사 분야가 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다.
북미는 첨단 의료 인프라와 의료 연구개발을 위한 막대한 자금으로 시장을 독점하고 있습니다.
아시아태평양은 중국, 인도 등 국가의 의료 부문 성장과 자가면역질환 유병률 증가로 인해 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다.
세계 주요 시장 진출기업으로는 Abbott, AESKU.DIAGNOSTICS, Beckman Coulter, BIOMERIEUX, Bio-Rad Laboratories, EUROIMMUN, F. Hoffmann-La Roche Ltd, Inova Diagnostics(Werfen Group), Myriad Genetics, Quest Diagnostics, Scipher Medicine, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 자가면역질환 진단 시장 인사이트
- 유형 현황
- 자가면역질환 진단 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
제5장 세계의 자가면역질환 진단 시장 : 제품별
- 주요 조사 결과
- 서론
- 소모품 및 어세이 키트
- 기기
제6장 세계의 자가면역질환 진단 시장 : 유형별
- 주요 조사 결과
- 서론
- 전신성 자가면역질환 진단
- 국소적 자가면역질환 진단
제7장 세계의 자가면역질환 진단 시장 : 검사 유형별
- 주요 조사 결과
- 서론
- 항핵 항체(ANA) 검사
- 자가 항체 검사
- 전혈구수(CBC)
- 종합적 대사 패널
- C반응성 단백질(CRP)
- 기타
제8장 세계의 자가면역질환 진단 시장 : 최종사용자별
- 주요 조사 결과
- 서론
- 병원
- 진단센터
- 연구실
제9장 세계의 자가면역질환 진단 시장 : 지역별
- 주요 조사 결과
- 서론
- 자가면역질환 진단 시장 평가 : 지역별, 2020년-2034년
- 북미
- 북미 : 제품별, 2020년-2034년
- 북미 : 유형별, 2020년-2034년
- 북미 : 검사 유형별, 2020년-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별, 2020년-2034년
- 유럽 : 유형별, 2020년-2034년
- 유럽 : 검사 유형별, 2020년-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 유형별, 2020년-2034년
- 아시아태평양 : 검사 유형별, 2020년-2034년
- 아시아태평양 : 최종사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 검사 유형별, 2020년-2034년
- 중동 및 아프리카 : 최종사용자별, 2020년-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별, 2020년-2034년
- 라틴아메리카 : 유형별, 2020년-2034년
- 라틴아메리카 : 검사 유형별, 2020년-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- Abbott
- AESKU.DIAGNOSTICS
- Beckman Coulter, Inc.
- BIOMERIEUX
- Bio-Rad Laboratories, Inc.
- EUROIMMUN
- F. Hoffmann-La Roche Ltd
- Inova Diagnostics(Werfen Group)
- Myriad Genetics, Inc.
- Quest Diagnostics
- Scipher Medicine
- Siemens Healthcare Private Limited
- Thermo Fisher Scientific Inc.
The global autoimmune disease diagnostics market size is expected to reach USD 7,146.32 million by 2034, according to a new study by Polaris Market Research. The report "Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.
The autoimmune disease diagnostics market is a sector within the healthcare and diagnostic industry. The market focuses on the identification and management of autoimmune diseases through advanced diagnostic tools and techniques. Autoimmune diseases occur when the immune system attacks the body's tissues, leading to a range of chronic and potential conditions. The market encompasses diagnostic tests and technologies used to detect these conditions, including blood tests, imaging techniques, and molecular assays.
The increasing prevalence of autoimmune diseases globally drives demand for early and accurate diagnostic tools. As awareness of these conditions grows, patients and healthcare providers seek more precise and efficient diagnostic solutions. Additionally, the rising adoption of personalized medicine and advanced treatment approaches necessitates accurate diagnostics, further boosting market growth. Government initiatives and funding for research into autoimmune diseases and diagnostics are contributing to the development of new diagnostic methods, thereby enhancing market opportunities.
In 2021, the Accelerating Medicines Partnership (AMP) program introduced the Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) program. The AMP Autoimmune and Immune-Mediated Diseases (AMP AIM) initiative is driving the market by increasing awareness and promoting early screening for autoimmune diseases.
The autoimmune disease diagnostics market is experiencing swift to advanced and automated diagnostic solutions that provide higher accuracy and faster results. Integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is transforming how autoimmune diseases are detected and monitored, improving efficiency and precision. Furthermore, there is an increasing focus on developing noninvasive diagnostic techniques, which provide a more patient-friendly alternative to traditional methods.
In July 2022, KSL Beutner Laboratories (Beutner) announced the launch of an indirect immunofluorescence (IIF) serum blood test in the US. The test effectively detects laminin 332, an antigen linked to the persistent autoimmune condition mucous membrane pemphigoid (MMP). These increasing developments in diagnostic methods drive the autoimmune disease diagnostics market growth.
Autoimmune Disease Diagnostics Market Report Highlights
Based on type, the systemic autoimmune disease diagnostics segment dominated the autoimmune disease diagnostics market revenue share, mainly attributed to increased awareness among healthcare providers and patients.
The antinuclear antibody (ANA) tests segment, by test type, is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.
North America dominated the market due to advanced healthcare infrastructure and substantial funding for medical research and development.
Asia Pacific is expected to register the highest CAGR during the forecast period, owing to growing healthcare sectors in countries such as China and India and the increasing prevalence of autoimmune diseases.
A few global key market players are Abbott; AESKU.DIAGNOSTICS; Beckman Coulter, Inc.; BIOMERIEUX; Bio-Rad Laboratories, Inc.; EUROIMMUN; F. Hoffmann-La Roche Ltd; Inova Diagnostics (Werfen Group); Myriad Genetics, Inc.; Quest Diagnostics; Scipher Medicine; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.
Polaris Market Research has segmented the autoimmune disease diagnostics market report on the basis of product, type, test type, end user, and region:
By Product Outlook (Revenue - USD Million, 2020-2034)
- Consumables and Assay Kits
- Instruments
By Type Outlook (Revenue - USD Million, 2020-2034)
- Systemic Autoimmune Disease Diagnostics
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus (SLE)
- Others
- Localized Autoimmune Disease Diagnostics
- Multiple Sclerosis
- Type 1 Diabetes
- Hashimoto's Thyroiditis
- Idiopathic Thrombocytopenic Purpura
- Others
By Test Type Outlook (Revenue - USD Million, 2020-2034)
- Antinuclear Antibody (ANA) Tests
- Autoantibody Tests
- Complete Blood Count (CBC)
- Comprehensive Metabolic Panel
- C-Reactive Protein (CRP)
- Others
By End User Outlook (Revenue - USD Million, 2020-2034)
- Hospitals
- Diagnostics Centers
- Research Laboratories
By Regional Outlook (Revenue - USD Million, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Australia
- Vietnam
- Malaysia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Autoimmune Disease Diagnostics Market Insights
- 4.1. Autoimmune Disease Diagnostics Market - Type Snapshot
- 4.2. Autoimmune Disease Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased Awareness and Screening Programs
- 4.2.1.2. Rising Healthcare Expenditure and Investments in Research
- 4.2.1. Drivers and Opportunities
- 4.3. Restraints and Challenges
- 4.3.1.1. Prolonged Turnaround Time for Results and Requirement for Multiple Diagnostic Tests
- 4.4. Porter's Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers (Moderate)
- 4.4.2. Threats of New Entrants (Low)
- 4.4.3. Bargaining Power of Buyers (Moderate)
- 4.4.4. Threat of Substitute (Moderate)
- 4.4.5. Rivalry Among Existing Firms (High)
- 4.5. PESTEL Analysis
- 4.6. Autoimmune Disease Diagnostics Market Type Trends
- 4.7. Value Chain Analysis
- 4.8. COVID-19 Impact Analysis
5. Global Autoimmune Disease Diagnostics Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 5.3. Consumables and Assay Kits
- 5.3.1. Global Autoimmune Disease Diagnostics Market, by Consumables and Assay Kits, by Region, 2020-2034 (USD million)
- 5.4. Instruments
- 5.4.1. Global Autoimmune Disease Diagnostics Market, by Instruments, by Region, 2020-2034 (USD million)
6. Global Autoimmune Disease Diagnostics Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 6.3. Systemic Autoimmune Disease Diagnostics
- 6.3.1. Global Autoimmune Disease Diagnostics Market, by Systemic Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
- 6.3.2. Rheumatoid Arthritis
- 6.3.2.1. Global Autoimmune Disease Diagnostics Market, by Rheumatoid Arthritis, by Region, 2020-2034 (USD million)
- 6.3.3. Ankylosing Spondylitis
- 6.3.3.1. Global Autoimmune Disease Diagnostics Market, by Ankylosing Spondylitis, by Region, 2020-2034 (USD million)
- 6.3.4. Systemic Lupus Erythematosus (SLE)
- 6.3.4.1. Global Autoimmune Disease Diagnostics Market, by Systemic Lupus Erythematosus (SLE), by Region, 2020-2034 (USD million)
- 6.3.5. Others
- 6.3.5.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)
- 6.4. Localized Autoimmune Disease Diagnostics
- 6.4.1. Global Autoimmune Disease Diagnostics Market, by Localized Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
- 6.4.2. Multiple Sclerosis
- 6.4.2.1. Global Autoimmune Disease Diagnostics Market, by Multiple Sclerosis, by Region, 2020-2034 (USD million)
- 6.4.3. Type 1 Diabetes
- 6.4.3.1. Global Autoimmune Disease Diagnostics Market, by Type 1 Diabetes, by Region, 2020-2034 (USD million)
- 6.4.4. Hashimoto's Thyroiditis
- 6.4.4.1. Global Autoimmune Disease Diagnostics Market, by Hashimoto's Thyroiditis, by Region, 2020-2034 (USD million)
- 6.4.5. Idiopathic Thrombocytopenic Purpura
- 6.4.5.1. Global Autoimmune Disease Diagnostics Market, by Idiopathic Thrombocytopenic Purpura, by Region, 2020-2034 (USD million)
- 6.4.6. Others
- 6.4.6.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)
7. Global Autoimmune Disease Diagnostics Market, by Test Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 7.3. Antinuclear Antibody (ANA) Tests
- 7.3.1. Global Autoimmune Disease Diagnostics Market, by Antinuclear Antibody (ANA) Tests, by Region, 2020-2034 (USD million)
- 7.4. Autoantibody Tests
- 7.4.1. Global Autoimmune Disease Diagnostics Market, by Autoantibody Tests, by Region, 2020-2034 (USD million)
- 7.5. Complete Blood Count (CBC)
- 7.5.1. Global Autoimmune Disease Diagnostics Market, by Complete Blood Count (CBC) , by Region, 2020-2034 (USD million)
- 7.6. Comprehensive Metabolic Panel
- 7.6.1. Global Autoimmune Disease Diagnostics Market, by Comprehensive Metabolic Panel, by Region, 2020-2034 (USD million)
- 7.7. C-Reactive Protein (CRP)
- 7.7.1. Global Autoimmune Disease Diagnostics Market, by C-Reactive Protein (CRP), by Region, 2020-2034 (USD million)
- 7.8. Others
- 7.8.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)
8. Global Autoimmune Disease Diagnostics Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 8.3. Hospitals
- 8.3.1. Global Autoimmune Disease Diagnostics Market, by Hospitals, by Region, 2020-2034 (USD million)
- 8.4. Diagnostics Centers
- 8.4.1. Global Autoimmune Disease Diagnostics Market, by Diagnostics Centers, by Region, 2020-2034 (USD million)
- 8.5. Research Laboratories
- 8.5.1. Global Autoimmune Disease Diagnostics Market, by Research Laboratories, by Region, 2020-2034 (USD million)
9. Global Autoimmune Disease Diagnostics Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Autoimmune Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD million)
- 9.3. Autoimmune Disease Diagnostics Market - North America
- 9.3.1. North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.3.2. North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.3.3. North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.3.4. North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.3.5. Autoimmune Disease Diagnostics Market - US
- 9.3.5.1. US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.3.5.2. US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.3.5.3. US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.3.5.4. US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.3.6. Autoimmune Disease Diagnostics Market - Canada
- 9.3.6.1. Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.3.6.2. Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.3.6.3. Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.3.6.4. Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4. Autoimmune Disease Diagnostics Market - Europe
- 9.4.1. Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.2. Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.3. Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.4. Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.5. Autoimmune Disease Diagnostics Market - UK
- 9.4.5.1. UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.5.2. UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.5.3. UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.5.4. UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.6. Autoimmune Disease Diagnostics Market - France
- 9.4.6.1. France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.6.2. France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.6.3. France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.6.4. France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.7. Autoimmune Disease Diagnostics Market - Germany
- 9.4.7.1. Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.7.2. Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.7.3. Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.7.4. Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.8. Autoimmune Disease Diagnostics Market - Italy
- 9.4.8.1. Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.8.2. Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.8.3. Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.8.4. Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.9. Autoimmune Disease Diagnostics Market - Spain
- 9.4.9.1. Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.9.2. Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.9.3. Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.9.4. Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.10. Autoimmune Disease Diagnostics Market - Netherlands
- 9.4.10.1. Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.10.2. Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.10.3. Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.10.4. Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.11. Autoimmune Disease Diagnostics Market - Russia
- 9.4.11.1. Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.11.2. Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.11.3. Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.11.4. Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.12. Autoimmune Disease Diagnostics Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.12.2. Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.12.3. Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.12.4. Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5. Autoimmune Disease Diagnostics Market - Asia Pacific
- 9.5.1. Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.2. Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.3. Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.4. Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.5. Autoimmune Disease Diagnostics Market - China
- 9.5.5.1. China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.5.2. China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.5.3. China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.5.4. China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.6. Autoimmune Disease Diagnostics Market - India
- 9.5.6.1. India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.6.2. India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.6.3. India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.6.4. India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.7. Autoimmune Disease Diagnostics Market - Malaysia
- 9.5.7.1. Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.7.2. Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.7.3. Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.7.4. Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.8. Autoimmune Disease Diagnostics Market - Japan
- 9.5.8.1. Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.8.2. Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.8.3. Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.8.4. Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.9. Autoimmune Disease Diagnostics Market - Indonesia
- 9.5.9.1. Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.9.2. Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.9.3. Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.9.4. Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.10. Autoimmune Disease Diagnostics Market - South Korea
- 9.5.10.1. South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.10.2. South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.10.3. South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.10.4. South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.11. Autoimmune Disease Diagnostics Market - Australia
- 9.5.11.1. Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.11.2. Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.11.3. Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.11.4. Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.12. Autoimmune Disease Diagnostics Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.12.2. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.12.3. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.12.4. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6. Autoimmune Disease Diagnostics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.2. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.3. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.4. Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.5. Autoimmune Disease Diagnostics Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.5.2. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.5.3. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.5.4. Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.6. Autoimmune Disease Diagnostics Market - UAE
- 9.6.6.1. UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.6.2. UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.6.3. UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.6.4. UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.7. Autoimmune Disease Diagnostics Market - Israel
- 9.6.7.1. Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.7.2. Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.7.3. Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.7.4. Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.8. Autoimmune Disease Diagnostics Market - South Africa
- 9.6.8.1. South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.8.2. South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.8.3. South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.8.4. South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.9. Autoimmune Disease Diagnostics Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.9.2. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.9.3. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.9.4. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7. Autoimmune Disease Diagnostics Market - Latin America
- 9.7.1. Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.7.2. Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.7.3. Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.7.4. Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.5. Autoimmune Disease Diagnostics Market - Mexico
- 9.7.5.1. Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.7.5.2. Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.7.5.3. Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.7.5.4. Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.6. Autoimmune Disease Diagnostics Market - Brazil
- 9.7.6.1. Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.7.6.2. Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.7.6.3. Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.7.6.4. Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.7. Autoimmune Disease Diagnostics Market - Argentina
- 9.7.7.1. Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.7.7.2. Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.7.7.3. Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.7.7.4. Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.8. Autoimmune Disease Diagnostics Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.7.8.2. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.7.8.3. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.7.8.4. Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. AESKU.DIAGNOSTICS
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Beckman Coulter, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. BIOMERIEUX
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Bio-Rad Laboratories, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. EUROIMMUN
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. F. Hoffmann-La Roche Ltd
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Inova Diagnostics (Werfen Group)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Myriad Genetics, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Quest Diagnostics
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Scipher Medicine
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Siemens Healthcare Private Limited
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Thermo Fisher Scientific Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
샘플 요청 목록